Common Contracts
1 similar Study Agreement contracts
ContractStudy Agreement • January 27th, 2022
AMENDMENT #1 TO CLINICAL STUDY AGREEMENT DODATEK # 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ This Amendment (the "Amendment") to the Clinical Study Agreement, dated 02Sep2021 (the “Agreement”), for the clinical study (the “Study”) sponsored by Da Volterra and conducted in accordance with the protocol DAV132-CL-3001 “A multicenter, randomized, placebo-controlled, parallel- arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy (MICROCARE)” and any amendments thereto (the “Protocol”), is made by and between: Tento Dodatek (dále jen „Dodatek“) ke Smlouvě o klinickém hodnocení uzavřené dne 2.9. 2021 (dále jen „Smlouva“) ke klinické studii (dále jen„Studie“) zadané společností Da Volterra a prováděné v souladu s protokolem DAV132-CL- 3001 „Multicentrická randomizovaná placebem kontrolovaná klinická studie s paralelními s
